Isoniazid protects mice against endotoxin lethality without influencing tumor necrosis factor synthesis and release.

AUTOR(ES)

Urbaschek, R

RESUMO

Treatment of NMRI mice with isoniazid (INH; 25 mg/kg) intraperitoneally induced significant protection when it was injected before or after a lethal intravenous challenge with endotoxin. The INH preparation used was not contaminated with endotoxin. Tumor necrosis factor (TNF) was not elevated in sera from NMRI mice 2 h after the injection of INH. INH did not influence TNF synthesis or release determined in human monocytes in vitro. Therefore, it is concluded that the protective effect of INH against lethal endotoxin is not due to a suppressive effect of INH on TNF production.

Documentos Relacionados

• Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production.
• Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.
• Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice.
• Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection.
• Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.